This inventor holds 4 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignee: The Methodist Hospital. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: Martyn Alun Sharpe: Innovator in Oncomagnetic Treatment
Introduction
Martyn Alun Sharpe is a notable inventor based in Houston, Texas, recognized for his contributions to medical technology. He holds three patents that focus on innovative methods for cancer treatment, particularly through the use of oscillating magnetic fields.
Latest Patents
Sharpe's latest patents include a method and apparatus for oncomagnetic treatment aimed at disrupting mitochondrial function in specific cells. This invention involves controlling hardware to cause a magnet to oscillate, generating an oscillating magnetic field. The field is applied to a volume of tissue containing cells with degraded mitochondria, triggering apoptosis in those cells. Another patent elaborates on non-invasive cancer treatments utilizing oscillating magnetic fields to induce apoptosis or other mechanisms of cell death in cancer cells. This disclosure also includes a device designed to provide oncomagnetic field treatment to subjects.
Career Highlights
Martyn Alun Sharpe is affiliated with The Methodist Hospital, where he applies his expertise in developing advanced medical technologies. His work is pivotal in the ongoing research and development of innovative cancer treatments.
Collaborations
Sharpe collaborates with esteemed colleagues, including David S. Baskin and Santosh Anand Helekar, contributing to a dynamic research environment focused on improving patient outcomes through technological advancements.
Conclusion
Martyn Alun Sharpe's innovative work in oncomagnetic treatment exemplifies the intersection of technology and medicine, showcasing his commitment to advancing cancer treatment methodologies. His contributions are significant in the field of medical research and technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
